In conclusion, our results add to previous evidence implicating the endocannabinoid system with neurodevelopmental disorders, such as SSD, and represent new evidence regarding the CNR1 gene in the development and variability of dermatoglyphic patterns. Here, CNR1 is linked to neurodevelopmental disorder.